HAWKEY, C. J., JACKSON, L., HARPER, S. E., SIMON, T. J., MORTENSEN, E., & LINES, C. R. (2001). Review article: The gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans. Alimentary pharmacology & therapeutics, 15(1), 1-9. https://doi.org/10.1046/j.1365-2036.2001.00894.x
Chicago Style (17th ed.) CitationHAWKEY, C. J., L. JACKSON, S. E. HARPER, T. J. SIMON, E. MORTENSEN, and C. R. LINES. "Review Article: The Gastrointestinal Safety Profile of Rofecoxib, a Highly Selective Inhibitor of Cyclooxygenase-2, in Humans." Alimentary Pharmacology & Therapeutics 15, no. 1 (2001): 1-9. https://doi.org/10.1046/j.1365-2036.2001.00894.x.
MLA (9th ed.) CitationHAWKEY, C. J., et al. "Review Article: The Gastrointestinal Safety Profile of Rofecoxib, a Highly Selective Inhibitor of Cyclooxygenase-2, in Humans." Alimentary Pharmacology & Therapeutics, vol. 15, no. 1, 2001, pp. 1-9, https://doi.org/10.1046/j.1365-2036.2001.00894.x.